What's Next: BioXcel Therapeutics's Earnings Preview
What's Next: BioXcel Therapeutics's Earnings Preview
BioXcel Therapeutics (NASDAQ:BTAI) is set to give its latest quarterly earnings report on Thursday, 2024-11-14. Here's what investors need to know before the announcement.
bioxcel therapeutics (纳斯达克:BTAI) 将于2024年11月14日(星期四)发布最新的季度财报。以下是投资者在公告前需要了解的信息。
Analysts estimate that BioXcel Therapeutics will report an earnings per share (EPS) of $-0.52.
分析师估计bioxcel therapeutics的每股收益(EPS)为-$0.52。
The market awaits BioXcel Therapeutics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
市场期待bioxcel therapeutics的公告,希望能够超出预期并提供积极的下一个季度指引。
It's important for new investors to understand that guidance can be a significant driver of stock prices.
新投资者需要明白,指引对股价有重要影响。
Overview of Past Earnings
过去收益的概述
During the last quarter, the company reported an EPS beat by $0.50, leading to a 5.06% drop in the share price on the subsequent day.
在上个季度,该公司报告的每股收益超出预期$0.50,导致次日股价下跌5.06%。
Here's a look at BioXcel Therapeutics's past performance and the resulting price change:
以下是bioxcel therapeutics过去表现及相应的价格变动情况:
Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
---|---|---|---|---|
EPS Estimate | -0.71 | -0.70 | -0.91 | -1.31 |
EPS Actual | -0.21 | -0.87 | -0.76 | -1.58 |
Price Change % | -5.0% | -9.0% | 4.0% | 4.0% |
季度 | 2024年第二季度 | 2024年第一季度 | Q4 2023 | Q3 2023 |
---|---|---|---|---|
每股收益预估值 | -0.71 | -0.70 | -0.91 | -1.31 |
每股收益实际值 | -0.21 | -0.87 | -0.76 | -1.58 |
价格变更% | -5.0% | -9.0% | 4.0% | 4.0% |

Stock Performance
股票表现
Shares of BioXcel Therapeutics were trading at $0.665 as of November 12. Over the last 52-week period, shares are down 84.48%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
截至11月12日,bioxcel therapeutics的股价为0.665美元。在过去的52周里,股价下跌了84.48%。考虑到这些收益通常是负面的,长期股东在这次财报发布前可能会感到不满。
To track all earnings releases for BioXcel Therapeutics visit their earnings calendar on our site.
要跟踪bioxcel therapeutics的所有财报发布,请访问我们网站上的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文是由Benzinga的自动内容引擎生成,并由编辑审核。